Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11

Stock Information for Veru Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Veru Inc.

Veru to Present at the GLP-1 Based Therapeutics Summit
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Veru Announces Date of 2024 Annual Meeting of Shareholders
Veru Reschedules Annual Meeting of Shareholders
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss
Veru Reports Fiscal 2024 First Quarter Financial Highlights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.